Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
1979; Lippincott Williams & Wilkins; Volume: 60; Issue: 6 Linguagem: Inglês
10.1161/01.cir.60.6.1385
ISSN1524-4539
AutoresPatrice Jaillon, Roger A. Winkle,
Tópico(s)Electrochemical Analysis and Applications
ResumoHomeCirculationVol. 60, No. 6Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBElectrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships. P Jaillon and R A Winkle P JaillonP Jaillon and R A WinkleR A Winkle Originally published1 Dec 1979https://doi.org/10.1161/01.CIR.60.6.1385Circulation. 1979;60:1385–1394 eLetters(0) eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate. Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page. Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Chandler J, Monnet E and Staatz A (2006) Comparison of Acute Hemodynamic Effects of Lidocaine and Procainamide for Postoperative Ventricular Arrhythmias in Dogs, Journal of the American Animal Hospital Association, 10.5326/0420262, 42:4, (262-268), Online publication date: 1-Jul-2006. Kowey P, Marinchak R, Rials S and Bharucha D (2000) Classification and pharmacology of antiarrhythmic drugs, American Heart Journal, 10.1067/mhj.2000.106640, 140:1, (12-20), Online publication date: 1-Jul-2000. Kharidia J and Eddington N (1996) Application of Computer-Assisted Radiotelemetry in the Pharmacokinetic and Pharmacodynamic Modeling of Procainamide and N-Acetylprocainamide, Journal of Pharmaceutical Sciences, 10.1021/js950473h, 85:6, (595-599), Online publication date: 1-Jun-1996. Roden D (1993) Current status of class III antiarrhythmic drug therapy, The American Journal of Cardiology, 10.1016/0002-9149(93)90040-J, 72:6, (B44-B49), Online publication date: 1-Aug-1993. Wong W, Paviou H, Birgersdotter U, Hillernan D, Mohiuddin S and Roden D (1992) Pharmacology of the class 111 antiarrhythmic agent sematilide in patients with arrhythmias, The American Journal of Cardiology, 10.1016/0002-9149(92)91306-O, 69:3, (206-212), Online publication date: 1-Jan-1992. Schoels W, Yang H, Gough W and el-Sherif N (1991) Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway., Circulation Research, 68:4, (1117-1126), Online publication date: 1-Apr-1991. HUNT G and ROSS D (2006) Promotion of Ventricular Tachycardia Induction by Procainamide in Dogs with Inducible Ventricular Fibrillation Late After Myocardial Infarction, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1990.tb02125.x, 13:7, (882-889), Online publication date: 1-Jul-1990. TURGEON J, MURRAY K and RODEN D (2008) Effects of Drug Metabolism, Metabolites, and Stereoselectivity on Antiarrhythmic Drug Action, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1990.tb01065.x, 1:3, (238-260), Online publication date: 1-Jun-1990. Roden D (2008) Clinical features of arrhythmia aggravation by antiarrhythmic drugs and their implications for basic mechanisms, Drug Development Research, 10.1002/ddr.430190206, 19:2, (153-172), Online publication date: 1-Jan-1990. Jaillon P and Drici M (1989) Recent antiarrhythmic drugs, The American Journal of Cardiology, 10.1016/0002-9149(89)91203-4, 64:20, (J65-J69), Online publication date: 1-Dec-1989. Fish F and Roden D (2012) A Prolonged QTc Interval, Medical Toxicology and Adverse Drug Experience, 10.1007/BF03259922, 4:6, (400-411), Online publication date: 1-Dec-1989. Furukawa T, Rozanski J, Moroe K, Gosselin A and Lister J (1989) Efficacy of procainamide on ventricular tachycardia: Relation to prolongation of refractoriness and slowing of conduction, American Heart Journal, 10.1016/0002-8703(89)90582-6, 118:4, (702-708), Online publication date: 1-Oct-1989. Sheldon R, Hill R, Cannon N and Duff H (1989) Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channel., Circulation Research, 65:2, (477-482), Online publication date: 1-Aug-1989.Echt D, Black J, Barbey J, Coxe D and Cato E (1989) Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation., Circulation, 79:5, (1106-1117), Online publication date: 1-May-1989. Feld G, Nademanee K, Noll E and Singh B (1989) Oral N-acetylprocainamide compared to quinidine plus digoxin in the chronic suppression of atrial flutter in humans, Cardiovascular Drugs and Therapy, 10.1007/BF01883864, 3:2, (191-198), Online publication date: 1-Mar-1989. SCHWARTZ J and HERRE J (2006) The Electrophysiological Effects of Alpha‐Chloralose Anesthesia in the Intact Dog: (1) Alone and (2) in Combination with Verapamil, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1989.tb02661.x, 12:2, (283-293), Online publication date: 1-Feb-1989. Furukawa T, Herscovici H, Desai T, Sampsell R, Nogami A, Moroe K, Rozanski J and Lister J (2006) Rapid Assessment of Rate and Antiarrhythmic Drug Effect on the Myocardium Using Asymmetric Biphasic Pulse Stimulation, Pacing and Clinical Electrophysiology, 10.1111/pace.1989.12.p1.52, 12:P1, (52-64), Online publication date: 1-Jan-1989. Roden D (1988) Role of the electrocardiogram in determining electrophysiologic end points of drug therapy, The American Journal of Cardiology, 10.1016/0002-9149(88)90338-4, 62:12, (H34-H38), Online publication date: 1-Oct-1988. Woosley R (1988) Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugs, The American Journal of Cardiology, 10.1016/0002-9149(88)90335-9, 62:12, (H9-H17), Online publication date: 1-Oct-1988. Okumura K and Waldo A (1987) Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: Comparison with the effects of quinidine, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80474-6, 9:6, (1332-1338), Online publication date: 1-Jun-1987. Singh B, Feld G and Nademanee K (2022) Arrhythmia Control by Selective Lengthening of Cardiac Repolarization: Role of N-Acetylprocainamide, Active Metabolite of Procainamide, Angiology, 10.1177/000331978603701202, 37:12, (930-938), Online publication date: 1-Dec-1986. PAPICH M, DAVIS L and DAVIS C (2008) Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration, Journal of Veterinary Pharmacology and Therapeutics, 10.1111/j.1365-2885.1986.tb00056.x, 9:4, (359-369), Online publication date: 1-Dec-1986. KOWEY P and FRIEHLING T (2006) Uses and Limitations of Electrophysiology Studies for the Selection of Antiarrhythmic Therapy, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1986.tb05397.x, 9:2, (231-247), Online publication date: 1-Mar-1986. Roden D and Hoffman B (1985) Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length., Circulation Research, 56:6, (857-867), Online publication date: 1-Jun-1985. Roden D and Woosley R (1985) QT prolongation and arrhythmia suppression, American Heart Journal, 10.1016/0002-8703(85)90627-1, 109:2, (411-415), Online publication date: 1-Feb-1985. Ludden T, Crawford M and Kennedy G (2012) N ‐Acetylprocainamide Kinetics During Intravenous Infusions and Subsequent Oral Doses in Patients with Coronary Artery Disease and Ventricular Arrhythmias , Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1985.tb04450.x, 5:1, (11-15), Online publication date: 2-Jan-1985. Aronson J (1985) Cardiac glycosides and drugs used in dysrhythmias , 10.1016/S0378-6080(85)80022-2, (158-170), . WOOSLEY R, CERSKUS I and RODEN D (2013) Antiarrhythmic Therapy: Clinical Pharmacology Update, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1984.tb01838.x, 24:7, (295-305), Online publication date: 1-Jul-1984. Kates R, Woosley R and Harrison D (1984) Clinical importance of metabolites of antiarrhythmic drugs, The American Journal of Cardiology, 10.1016/0002-9149(84)90721-5, 53:1, (248-251), Online publication date: 1-Jan-1984. Cain M, Martin T, Marchlinski F and Josephson M (1983) Changes in ventricular refractoriness after an extrastimulus: Effects of prematurity, cycle length and procainamide, The American Journal of Cardiology, 10.1016/0002-9149(83)90519-2, 52:8, (996-1001), Online publication date: 1-Nov-1983. Kates R (1983) Plasma level monitoring of antiarrhythmic drugs, The American Journal of Cardiology, 10.1016/0002-9149(83)90626-4, 52:6, (C8-C13), Online publication date: 1-Sep-1983. Sung R, Juma Z and Saksena S (1983) Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias, American Heart Journal, 10.1016/0002-8703(83)90245-4, 105:5, (811-819), Online publication date: 1-May-1983. Roden D and Woosley R (1983) Class I antiarrhythmic agents: Quinidine, procainamide and N-acetylprocainamide, disopyramide, Pharmacology & Therapeutics, 10.1016/0163-7258(83)90012-8, 23:2, (179-191), Online publication date: 1-Jan-1983. Gettes L, Foster J and Simpson R (1983) Clinical use of antiarrhythmic drugs Cardiac therapy, 10.1007/978-1-4613-3855-0_8, (235-298), . Snyder D and Sobel B (1983) Medical management of ischemic heart disease Cardiac therapy, 10.1007/978-1-4613-3855-0_15, (481-535), . ENGEL T (2006) The Electropharmacology of Acute Drug Testing Using Pacemakers, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1982.tb02283.x, 5:4, (577-585), Online publication date: 1-Jul-1982. Woosley R, Roden D, Duff H and Oates J (1982) Selection of an antiarrhythmic drug for a sudden-death-prevention trial, American Heart Journal, 10.1016/0002-8703(82)90481-1, 103:4, (737-745), Online publication date: 1-Apr-1982. Badke F, Walsh R, Crawford M, Ludden T and O'Rourke R (1981) Hemodynamic effects of n-acetylprocainamide compared with procainamide in conscious dogs., Circulation, 64:6, (1142-1150), Online publication date: 1-Dec-1981. Kluger J, Leech S, Reidenberg M, Lloyd V and Drayer D (1981) Long-term antiarrhythmic therapy with acetylprocainamide, The American Journal of Cardiology, 10.1016/0002-9149(81)90330-1, 48:6, (1124-1132), Online publication date: 1-Dec-1981. Winkle R, Peters F, Kates R, Tucker C and Harrison D (1981) Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias., Circulation, 64:2, (290-296), Online publication date: 1-Aug-1981. Jaillon P, Rubenson D, Peters F, Mason J and Winkle R (1981) Electrophysiologic effects of N-acetylprocainamide in human beings, The American Journal of Cardiology, 10.1016/0002-9149(81)90225-3, 47:5, (1134-1140), Online publication date: 1-May-1981. Winkle R, Jaillon P, Kates R and Peters F (1981) Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide, The American Journal of Cardiology, 10.1016/0002-9149(81)90300-3, 47:1, (123-130), Online publication date: 1-Jan-1981. Roden D, Reele S, Higgins S, Wilkinson G, Smith R, Oates J and Woosley R (1980) Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide, The American Journal of Cardiology, 10.1016/0002-9149(80)90016-8, 46:3, (463-468), Online publication date: 1-Sep-1980. Mayorga-Cortes A, Castellanos A and Myerburg R (2018) LAHB obscuring RBBB., Circulation, 61:4, (866-867), Online publication date: 1-Apr-1980.Engler R (2018) Comparison of i.v. quinidine and disopyramide., Circulation, 61:4, (866-866), Online publication date: 1-Apr-1980.Jenni R and Vieli A (2018) PDA by Doppler echo., Circulation, 61:4, (865-865), Online publication date: 1-Apr-1980.Ahmad S (2018) Procainamide, NAPA and systemic lupus., Circulation, 61:4, (865-866), Online publication date: 1-Apr-1980. December 1, 1979Vol 60, Issue 6 Advertisement Article Information Metrics Copyright © 1979 by American Heart Associationhttps://doi.org/10.1161/01.CIR.60.6.1385 Originally publishedDecember 1, 1979 PDF download Advertisement
Referência(s)